ALK and lung carcinoma: In a study by Gaughan et al. non-smoker NSCLC patients who harbored EGFR mutations were shown to have a significantly higher rate of family history of lung cancer as compared with ALK- and KRAS-mutated cohorts, which suggests that EGFR mutations might involve in the heredity of lung cancer [13].